Korean Circ J.  2016 Sep;46(5):658-664. 10.4070/kcj.2016.46.5.658.

Epidemiology of Heart Failure in Korea: Present and Future

• Lee JH
• Lim NK
• Cho MC
• Park HY

• KMID: 2389623
• DOI: http://doi.org/10.4070/kcj.2016.46.5.658

Abstract

BACKGROUND AND OBJECTIVES
Heart failure (HF) is an important healthcare issue because of its high mortality, morbidity, and healthcare costs. The number of HF patients is increasing worldwide as a consequence of aging of the population. However, there are limited studies on the prevalence of HF in Korea. This study aimed to estimate the prevalence of HF, its comorbidities, and the projected population with HF in the future.
MATERIALS AND METHODS
The prevalence and comorbidity estimates of HF were determined using data from the 2002-2013 National Sample Cohort based on the National Health Information Database. We calculated the projected prevalence of HF by multiplying the estimated prevalence in 2013 by the projected population counts for 2015-2040.
RESULTS
The prevalence of HF in Korea was estimated to be 1.53% in 2013. The prevalence of HF in Korea is expected to increase by 2-fold, from 1.60% in 2015 to 3.35% in 2040. By 2040, more than 1.7 million Koreans are expected to have HF. In terms of comorbid diseases of HF, ischemic heart disease, hypertension, and diabetes mellitus were common (45.4%, 43.6%, and 49.1% in 2013, respectively). The prevalence rates of arrhythmia, valvular disease, and cardiomyopathy in HF patients were approximately 22.6%, 5.6%, and 3.1% in 2013, respectively.
CONCLUSION
This is the first nationwide report in Korea to demonstrate the prevalence and comorbidities of HF. These data may be used for the prevention and management of HF in Korea.

Keyword

Heart failure; Prevalence; Risk factor; Comorbidity; Projection

MeSH Terms

Aging
Arrhythmias, Cardiac
Cardiomyopathies
Cohort Studies
Comorbidity
Delivery of Health Care
Diabetes Mellitus
Epidemiology*
Health Care Costs
Heart Failure*
Heart*
Humans
Hypertension
Korea*
Mortality
Myocardial Ischemia
Prevalence
Risk Factors

Figure

• 

  Fig. 1 Prevalence of heart failure according to sex in 2002-2013.

• 

  Fig. 2 Estimated prevalence of heart failure by age group (National Insurance Service's sample cohort database, 2013).

• 

  Fig. 3 Comorbidities of heart failure patients in NHIS (2003 vs. 2013). IHD:ischemic heart disease, DM:diabetes mellitus.

• 

  Fig. 4 Prevalence of comorbid diseases according to age and sex in NHIS (2013). (A) Ischemic heart disease, (B) Hypertension, (C) Diabetes mellitus (DM), (D) Arrhythmia, (E) Valvular heart diseases and (F) Cardiomyopathy.

Reference

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015; 131:e29–e322.

2. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013; 6:606–619.

3. Okamoto H, Kitabatake A. The epidemiology of heart failure in Japan. Nihon Rinsho. 2003; 61:709–714.

4. Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ J. 2008; 72:489–491.

5. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H. CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study. Circ J. 2011; 75:823–833.

6. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J. 2013; 77:2209–2217.

7. Pillai HS, Ganapathi S. Heart failure in South Asia. Curr Cardiol Rev. 2013; 9:102–111.

8. Guo Y, Lip GY, Banerjee A. Heart failure in East Asia. Curr Cardiol Rev. 2013; 9:112–122.

9. Statistics Korea. Population projections for Korea: 2010-2060 (based on the 2010 census). Daejeon: Statistics Korea;2011.

10. Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide risk factors for heart failure: A systematic review and pooled analysis. Int J Cardiol. 2013; 168:1186–1194.

11. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149:209–216.

12. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008; 52:347–356.

13. Yang YN, Ma YT, Liu F, et al. Incidence and distributing feature of chronic heart failure in adult population of Xinjiang. Zhonghua Xin Xue Guan Bing Za Zhi. 2010; 38:460–464.

14. Chong AY, Rajaratnam R, Hussein NR, Lip GY. Heart failure in a multiethnic population in Kuala Lumpur, Malaysia. Eur J Heart Fail. 2003; 5:569–574.

15. Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2008; 117:2544–2565.

16. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355:251–259.

17. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355:260–269.

18. Shiba N, Shimokawa H. Chronic heart failure in Japan: Implications of the CHART studies. Vasc Health Risk Manag. 2008; 4:103–113.

19. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean heart failure (KorHF) registry. Korean Circ J. 2011; 41:363–371.

20. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail. 2014; 16:700–708.

21. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93:1137–1146.

22. Kajimoto K, Sato N, Keida T, et al. investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Association between length of stay, frequency of in-hospital death, and causes of death in Japanese patients with acute heart failure syndromes. Int J Cardiol. 2013; 168:554–556.

23. Abraham WT, Fonarow GC, Albert NM, et al. OPTIMIZE-HF Investigators and Coordinators. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008; 52:347–356.

24. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Survey Investigators. Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population. Eur Heart J. 2006; 27:2725–2736.

25. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, et al. JCARE-CARD Investigators. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: A report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J. 2012; 76:1920–1927.

26. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 1994; 72:2 Suppl. S3–S9.

27. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161:996–1002.